|
Beginning in 2002 and drawing upon it extensive patient-reported database and that of its collaborating partner Symfo, Phase V began a unique new electronic PDA platform for its questionnaires on quality of life, functional health status, symptoms and patient satisfaction and other "patient assessed" clinical measurements such as home blood glucose monitoring, continuous glucose monitoring and home-blood pressure monitoring. Phase V has recently collaborated with Symfo (USA), Inc. to transfer it paper patient diaries to PDA platforms. The success of the coupling of these technologies is also leading to new applications in clinical care for patient self-management of chronic diseases. Symfo is supplying the base technologies and secure portal for this research while Phase V® is designing a backend relational database amenable to sophisticated statistical algorithms and analysis. By combining the 18 years of outcomes assessment experience of Phase V with the engineering capability of Symfo the goal is to offer a user-friendly approach for disease management that will fit easily into the patient's daily routines.
|
